Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Determination of HSP60 Antiserum Titer

Heat Shock Protein 60 (HSP60) is a critical mitochondrial chaperonin involved in protein folding and stress response, making it a significant target in immunological research. Accurate determination of HSP60 antiserum titer is essential for validating antibody quality and ensuring reliable results in applications such as Western blotting, ELISA, and immunohistochemistry. This technical article outlines the standardized protocols and methodologies for quantifying the specific antibody concentration in antisera against HSP60.

HSP60

Technical Overview

The determination of HSP60 antiserum titer is a fundamental procedure in immunology aimed at quantifying the concentration of specific antibodies within a serum sample. The titer represents the highest dilution of the antiserum that still yields a detectable antigen-antibody reaction. This measurement is crucial for assessing the quality of the immunized host response and for optimizing the amount of reagent required for downstream experimental applications. Given the high conservation of HSP60 across species, precise titer determination ensures that the antiserum specifically recognizes the target protein without significant cross-reactivity.

Testing Samples

Serum Sources

The primary sample for this assay is the antiserum collected from host animals immunized with purified HSP60 antigen. Common host animals include rabbits, mice, and goats.

  • Rabbit polyclonal antiserum
  • Mouse monoclonal serum
  • Pre-immune serum (negative control)
  • Purified IgG fractions derived from antiserum

Testing Items

The testing focuses on evaluating the binding capacity and specificity of the antibodies against the HSP60 antigen.

  • Antibody Titer: The functional concentration of antibodies determined through serial dilution.
  • Specificity: Verification that the antiserum binds specifically to HSP60 and not to other cellular proteins.
  • Sensitivity: The lowest amount of HSP60 antigen that the antiserum can detect.

Testing Methods

Indirect ELISA Protocol

The Enzyme-Linked Immunosorbent Assay (ELISA) is the most widely used method for determining antiserum titer due to its high sensitivity and throughput capability.

  • Coating: Microtiter plates are coated with a purified HSP60 antigen solution and incubated overnight at 4 degrees Celsius.
  • Blocking: Non-specific binding sites are blocked using a buffer containing BSA or non-fat milk.
  • Primary Antibody Incubation: Serial dilutions of the HSP60 antiserum are added to the wells and incubated.
  • Secondary Antibody Incubation: An enzyme-conjugated secondary antibody specific to the host species is added.
  • Detection: A substrate solution is added, and the absorbance is measured to determine the endpoint titer.

Western Blotting Analysis

Western blotting serves as a complementary method to confirm specificity and estimate titer. The antiserum is applied to membranes containing transferred proteins from cell lysates. A positive result is indicated by a specific band at approximately 60 kDa. The titer is assessed by the highest dilution at which this specific band remains visible.

Applications

Validated HSP60 antiserum is utilized in various fields of biomedical research and diagnostics.

  • Autoimmune Disease Research: Investigating the role of HSP60 as an autoantigen in conditions like rheumatoid arthritis and diabetes.
  • Cell Stress Studies: Monitoring the upregulation of HSP60 under cellular stress conditions.
  • Cancer Biomarker Discovery: Analyzing HSP60 expression levels in tumor tissues.
  • Microbial Infection Analysis: Detecting bacterial HSP60 homologs (GroEL) in infectious disease studies.

FAQ

What is considered a high titer for HSP60 antiserum?

A high titer is typically defined as an absorbance value significantly above the negative control at a dilution of 1:10,000 or higher. For highly specific polyclonal antibodies, effective titers can sometimes reach 1:100,000.

How can non-specific binding be reduced during the assay?

Non-specific binding can be minimized by optimizing the blocking buffer composition, extending blocking time, and adding detergents like Tween-20 to the wash buffers. Using a purified antigen for coating also improves specificity.

Why is pre-immune serum necessary for the test?

Pre-immune serum is essential as a negative control. It establishes the baseline background signal of the host animal's serum before immunization, ensuring that the detected signal in the antiserum is due to specific antibodies induced by the HSP60 antigen.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing